Unveiling 6 Analyst Insights On Corteva

During the last three months, 6 analysts shared their evaluations of Corteva CTVA, revealing diverse outlooks from bullish to bearish.

The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 2 2 2 0 0
Last 30D 1 0 0 0 0
1M Ago 0 2 2 0 0
2M Ago 0 0 0 0 0
3M Ago 1 0 0 0 0

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $62.33, a high estimate of $67.00, and a low estimate of $57.00. This upward trend is apparent, with the current average reflecting a 6.55% increase from the previous average price target of $58.50.

price target chart

Diving into Analyst Ratings: An In-Depth Exploration

An in-depth analysis of recent analyst actions unveils how financial experts perceive Corteva. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Edlain Rodriguez Mizuho Raises Buy $61.00 $56.00
Kristen Owen Oppenheimer Raises Outperform $67.00 $62.00
Jeffrey Zekauskas JP Morgan Lowers Neutral $57.00 $58.00
Benjamin Theurer Barclays Raises Equal-Weight $58.00 $55.00
Aleksey Yefremov Keybanc Raises Overweight $66.00 $63.00
Christopher Kapsch Loop Capital Raises Buy $65.00 $57.00

Key Insights:

  • Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Corteva. This information offers a snapshot of how analysts perceive the current state of the company.
  • Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Corteva compared to the broader market.
  • Price Targets: Analysts predict movements in price targets, offering estimates for Corteva's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.

Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Corteva's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.

Stay up to date on Corteva analyst ratings.

Unveiling the Story Behind Corteva

Corteva is an agriculture pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop chemicals products. Seeds generate a little over half of profits with the remainder coming from crop protection chemicals. Although Corteva operates globally, around half of revenue comes from North America.

Corteva: A Financial Overview

Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.

Revenue Growth: Corteva's revenue growth over a period of 3 months has faced challenges. As of 31 December, 2023, the company experienced a revenue decline of approximately -3.08%. This indicates a decrease in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Materials sector.

Net Margin: Corteva's net margin is impressive, surpassing industry averages. With a net margin of -6.82%, the company demonstrates strong profitability and effective cost management.

Return on Equity (ROE): Corteva's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -1.01%, the company may face hurdles in achieving optimal financial performance.

Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of -0.59%, the company showcases effective utilization of assets.

Debt Management: Corteva's debt-to-equity ratio is below the industry average. With a ratio of 0.1, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.

Analyst Ratings: What Are They?

Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.

Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: Analyst RatingsBZI-AAR
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!